With more than 30 years of experience in the area biopharmaceutical contract manufacturing as a Quality Assurance leader, Edwin Miranda was chosen as the Vice President of Quality at Cytovance Biologics in January of 2018. Cytovance is an Oklahoma-based company with state-of-the-art facilities that is involved with the production of therapeutic proteins and antibodies that are developed from mammalian cell culture and microbial fermentation, and cell banking and support services. Before joining the company, Edwin Miranda held positions at several pharmaceutical companies, and at Piramal Critical Care.
One of his greatest accomplishments was leading the Quality Assurance team that was successful in getting the FDA to approve the launch of a new drug called Keppra. When he was recently interviewed about his success in his chosen career, Edwin Miranda said that one of the things that makes him more productive as a business executive is the fact that he wakes up early each morning to get a jump on his day. By 5:30 am, he starts checking messages he received from his clients, and reading news feeds to stay aware of important matters, and projects he has to complete. He also sets aside time to exercise and interact with his family during those early morning hours.
Edwin Miranda, who is a US Army veteran, earned his Bachelor of Science degree in Biology and Chemistry from Angelo State University in San Angelo, Texas, and he also attended the School of Kinesiology to study the mechanics of body movements in humans and animals at the University of Michigan as a PhD student. The Vice President of Research and Development at Cytovance Biologics, Dr. Jesse McCool, Sr., has said that he feels the Quality Assurance expert is a tremendous asset to the company, due to the depth of his experience, knowledge and leadership skills.
To know more visit @: edwin-miranda.com/